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Objective: We evaluated whether active(a)-tDCS combined with hypnotic analgesia sug-
gestion (HS) would be more effective than a single active(a)-tDCS, and/or sham-(s)-tDCS 
and s-tDCS/HS on the following outcomes: function of descending pain modulatory system 
(DPMS) during the conditioned pain modulation test (CPM-test) (primary outcome), heat 
pain threshold (HPT), heat pain tolerance (HPTo) and cold pressor test (CPT) (secondary 
outcomes). We also examined whether their effects are related to neuroplasticity state 
evaluated by serum brain-derived-neurotropic factor (BDNF).
Materials and Methods: Forty-eight females received one session of one of the four 
interventions (a-tDCS/HS, s-tDCS/HS, a-tDCS, and s-tDCS) in an incomplete randomized 
crossover sequence. The a-tDCS or s-tDCS was applied over the left dorsolateral prefrontal 
cortex (DLPFC) for 30 minutes at 2mA.
Results: A generalized linear model revealed a significant main effect for the intervention 
group (P <0.032). The delta-(Δ) pain score on the Numerical Pain Scale (NPS0-10) during 
CPM-test in the a-tDCS/HS group was −0.25 (0.43). The (Δ) pain score on NPS (0–10) 
during CPM-test in the other three groups was a-tDCS=−0.54 (0.41), HS −0.01 (0.41) and s- 
tDCS/HS=−0.19 (0.43). A-tDCS/HS intervention increased the CPT substantially compared 
to all other interventions. Also, higher baseline levels of BDNF were associated with a larger 
change in CPT and HPTo.
Conclusion: These findings indicate that the HS combined with a-tDCS mitigated the effect 
of the a-tDCS on the DPMS. The a-tDCS up-regulates the inhibition on DPMS, and the HS 
improved pain tolerance. And, together they enhanced the reaction time substantially upon 
the CPT.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03744897.
Keywords: tDCS, hypnotic analgesia, conditioned pain modulation, pain perception
Introduction
Although we have witnessed a leap forward in comprehension in pain pathophy-
siology, a gap persists between pain research and pain management in clinical 
settings. The chronic pain is more prevalent in women (eg, migraine, fibromyalgia, 
irritable bowel syndrome, and temporomandibular disorders).1 Differences between 
sex on pain processing revealed that women, compared to men, showed higher 
medial prefrontal activation during the nociceptive stimulus.2 Women also showed 
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higher connectivity between the periaqueductal gray 
(PAG) and the middle cingulate cortex.3 And in a recent 
study, we found the higher inhibitory function of the 
descending pain modulating system (DPMS) in females 
compared to males.4 The DPMS comprises midbrain and 
medullar sites to control over nociception bidirectionally. 
The periaqueductal gray (PAG) receives inputs from 
higher brain centers and projects down to the spinal dorsal 
horn neurons to inhibit (modulate) pain transmission infor-
mation carried by pain fibers.5,6 Also, the rostroventrome-
dial medulla (RVM) can both facilitate or inhibit 
nociceptive inputs and acts as a final relay in the control 
of descending pain facilitation.7 The dysfunction of the 
DPMS has been pointed out as a central mechanism of 
chronic pain,8 which can be evaluated by the conditioned 
pain modulation (CPM) paradigm. During CPM-test, the 
nociceptive heterotopic stimuli activate the descending 
inhibitory control (DNIC), and it produces a phenomenon 
where “pain-inhibits pain”.9,10
Although the pharmacological treatment has advanced, 
the response is heterogeneous among patients with the same 
diagnosis by several factors, such as the severity of disease 
and genetic, emotional, sex hormonal, and other factors 
related to the dysfunction of DPMS.8 The anodal-(a)-tDCS 
is a promising therapy for chronic pain because it may 
change the dysfunctional plasticity within pain circuits 
according to the specific polarity of the electrodes.11 The 
anodic current increases neuronal excitability.12 While the 
cathodic stimulation causes hyperpolarization, with a reduc-
tion in the excitability of the neuronal.11,13,14 According to 
earlier studies, the a-tDCS could modulate pain systems by 
altering excitability at the cortical level,15 in thalamic and 
sub-thalamic regions1,16 and it enhances the strength of the 
DPMS.17 However, studies indicate that the effect of tran-
scranial direct current stimulation (tDCS) in healthy subjects 
is sex-dependent. The a-tDCS administered over the dorso-
lateral prefrontal cortex (DLPFC) produces a current flow to 
frontal regions higher in females,18 and another study found 
better performance in cognitive response to tDCS effects in 
women.19
The tDCS effect is related to the electrode’s places. 
Cumulative evidence has demonstrated that anodal(a)- 
tDCS montage applied over the primary motor cortex 
(M1) reduces pain levels.20 In contrast, its effect over the 
dorsolateral prefrontal cortex (DLPFC) with anodal at left 
and cathodal at right DLPFC can significantly improve 
pain perception.21 In recent n a recent study, using this 
montage in a home-based (HB) a-tDCS during twelve 
weeks for a total of 60 sessions, we observed significant 
improvement on the cardinal symptoms of fibromyalgia: 
pain level, psychological symptoms, sleep quality, and 
disability due to pain.22 Another study with healthy volun-
teers found that anodal applied on the left DLPFC modu-
lated pain perception.23 Likewise, an earlier study showed 
that the same montage of a-tDCS upregulates reactions to 
positive emotional stimuli and the identification of positive 
emotions.24 Electrodes placed on the biparietal cortices 
produce bi hemispherical stimulation.25 This approach 
can be used purposefully to up regulate one region of the 
brain, while down-regulates another.26
According to recent study, we found that anodal stimu-
lation over left DLPFC and cathodal over right DLPFC 
improved the inhibitory function of the DPMS, while 
hypnotic analgesia suggestion (HS) changes the pain 
perception.27 Although the mechanisms underpinning 
these effects are not entirely understood, these results are 
intriguing. And, they give us new insight into the mechan-
ism involved in hypnotic suggestion analgesia, which 
likely changes the cortical pain processing, whereas a- 
tDCS induced either downregulation of the pain-facilitat-
ing pathways or upregulation of the inhibitory function of 
the DPMS.28 And, its effect was modulated positively by 
the serum brain-derived-neurotropic factor (BDNF).28
Hypnotic analgesia is a social interaction in which one 
person (the subject) responds to suggestions given by 
another person (the hypnotist) to produce creative experi-
ences that involve changes in perception, memory, and 
voluntary control.29,30 According to a meta-analysis, 
which included both laboratory and clinical studies, the 
effect size (ES) of hypnotic analgesia was moderate (ES = 
0.71).31 The influence of hypnotic analgesia to decrease 
the activity in supraspinal areas identified as components 
of the pain matrix, including the thalamus, sensory cor-
tices, insula, anterior cingulate cortex (CCA), and the 
frontal area, has been demonstrated in previous studies.27 
Also, earlier studies found that hypnotic analgesia dissoci-
ates sensory and affective components of the pain experi-
ence according to the suggestion32 and modulates the 
activity/connectivity of the pain matrix. In the same way, 
hypnotic analgesia reduced the unpleasantness of thermal 
pain perception and modulated the neural activity in the 
CCA by the changes in thermal pain perception as 
assessed by positron emission tomography (PET).33 
Another study found that hypnotic analgesia effects in 
the somatosensory brain processing may be related to 
top-down somatosensory inhibition.32
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Thus, we plan the current study to test our hypothesis 
under an experimental paradigm in which we can charac-
terize the relationship between etiological components of 
pain (eg, nature, localization, intensity, frequency, and 
duration of the trigger necessary to evoke pain). We 
assumed that the HS effects on pain perception involve 
cortical pain processing. In contrast, the a-tDCS could 
down-regulate the pain-facilitating pathways, or it up-reg-
ulates the inhibitory function of the DPMS. Our purpose 
was to assess how the combined therapy (a-tDCS over left 
DLPFC and cathodal over right DLPFC combined with a 
hypnotic analgesia suggestion (HS)) would work in the 
pain processing based on measures to evaluate the pain 
perception (ie, pain threshold and pain tolerance) and the 
inhibitory function of DPMS by the CPM-test. We aimed 
to compare whether active(a)-tDCS combined with HS 
would be more effective than a single active(a)-tDCS, 
and/or sham-(s)-tDCS or s-tDCS/HS on the following out-
comes: function of DPMS assessed by the change on 
Numerical Pain Scale (NPS 0–10) during the conditioned 
pain modulation (CPM-test) (primary outcome), heat pain 
threshold (HPT), heat pain tolerance (HPTo) and cold 
pressor test (CPT) (secondary outcomes). We also exam-
ined whether their effects are related to neuroplasticity 
state evaluated by serum brain-derived-neurotropic factor 
(BDNF).
Materials and Methods
Design Overview, Setting, and 
Participants
We conducted a randomized blinded crossover sham-con-
trolled clinical study. The study was approved by the 
Research Ethics Committee (CEP) at the Hospital de 
Clínicas de Porto Alegre (HCPA) (Plataforma Brasil 
CAAE: 63,863,816,000,005,327 and CEP no: 16–0635) 
according to international ethical standards based on the 
Declaration of Helsinki. All participants were given writ-
ten informed consent. The protocol was pre-registered at 
ClinicalTrials.gov under the number NCT03744897.
Subjects
The volunteers were healthy women ranging between 18 
to 45 years old with more than 11 years of studies. They 
were recruited from the general population by advertise-
ment postings in the universities, on the internet, and 
personal divulgation and invitation in public places in the 
Porto Alegre area.
We included 48 subjects with a score greater than or 
equal to 8/12 on the scale in the Waterloo-Stanford Group 
Scale of Hypnotic Susceptibility, Form C (WSGC).34 The 
participants also answered a structured demographic ques-
tionnaire assessing the following variables: current acute 
or chronic pain conditions, use of analgesics in the past 
week, rheumatologic disease, clinically significant or 
unstable medical or psychiatric disorder, history of alcohol 
or substance abuse in the past 6 months, neuropsychiatric 
comorbidity, and use of psychotropic drugs. They were 
excluded if presenting any of these variables or if hearing 
impairment or formal contraindication to transcranial 
direct-current stimulation (a-tDCS). Those subjects with 
scores higher than 12 on Beck Depression Inventory35 
were also excluded, as were those with positive screening 
(>7) for minor psychiatric disorders (somatic symptoms, 
depressive moods, depressive thoughts, and decreased 
energy) on the World Health Organization (OMS) Self- 
Reporting Questionnaire (SRQ-20).
Experimental Protocol
Participants were randomized into four groups: (1) a- 
tDCS, (2) HS, (3) a-tDCS/HS and (4) s-tDCS/HS. It was 
an incomplete cross-over trial. The first group received 
single interventions in a cross-over manner (half received 
a sequence with HS first and later received a-tDCS; the 
other half received the opposite sequence). Another group 
received combined interventions (they were allocated to 
receive a sequence with an a-tDCS/HS or s-tDCS/HS, 
those receive a-tDCS/HS during the first trial received s- 
tDCS/HS in the second trial, or vice-versa). To avoid 
carry-over effects, we established a washout time of a 
minimum of seven days between the first and the second 
trial. Figure 1 presents the flowchart and progress through 
the study.
Interventions
Transcranial Direct Current Stimulation
tDCS was applied using Starstim 8 equipment 
(Neuroelectrics, Barcelona, Spain). Cathodal and anodal 
electrodes featured an area of 25 cm2 each placed inside a 
round sponge soaked in saline solution. Electrodes were 
placed at spatial positions F3-(Anodal) and F4-(Cathodal) 
according to the international 10–20-system for electroen-
cephalogram electrode placement,36 commonly considered 
surface locations above (mid-) left and right DLPFC, 
respectively.37 Stimulation was delivered at an intensity 
of 2 mA for 20 min, including a 30s ramp up to 2 mA at 
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the start and a 30s ramp down to 0 mA at the end. In the 
sham group, current was initially ramped to 2 mA over 30 
s and then immediately ramped down to 0 mA. In the final 
30 s, the current ramped up to 2mA and back to 0 mA. 
During stimulation, participants were asked to relax their 
bodies while sitting and supported in a comfortable 
position.
Hypnotic Analgesia Suggestion Protocol Based on the 
Classical Approach
The techniques of hypnosis developed for this study are 
found on the classical approach developed by the 
American clinician and Ph.D. Mark P Jensen.38 To guar-
antee that the hypnotic analgesia suggestion would be 
conducted equally in all subjects, only one psychologist 
with more than ten years of experience in practicing hyp-
notherapy conducted all HS sessions. The standard hypno-
tic protocol begins with an induction to the subjects to 
focus their attention on a single stimulus and associate this 
with breathing and relaxation. Through the 8 final minutes 
of the induction, suggestions were used to reduce the pain 
of the participants and increase control over their own 
sensations.39 We used the protocol of HS previously pub-
lished by Jansen,28 which follows standardized steps (see 
the hypnotic analgesia suggestion protocol in the 
Supplemental material (Appendix I)). The duration of 
experimental manipulation (induction + suggestions) is 
20 min.
a-tDCS/Hypnotic Suggestion and s-tDCS/ 
Hypnotic Suggestion
The a-tDCS/HS were performed concomitantly. When the 
a-tDCS stimulator was turned on, the therapist began the 
hypnosis induction as previously described. This session 
was conducted throughout the 20 min of the tDCS, ending 
with the final stimulation ramp, with the amperage reduced 
to zero. The s-tDCS/HS also had a protocol of 20 min 
duration. The hypnosis induction started with the initial 
30s current ramp up to 2 mA, and then the current was 
Figure 1 Flowchart of the study showing recruitment and progress through the study. 
Abbreviations: a-tDCS, active transcranial direct-current stimulation; CPM-test, conditioned pain modulation test; HS, hypnotic suggestion; s-tDCS, sham transcranial 
direct-current stimulation.
Beltran Serrano et al                                                                                                                                                Dovepress
submit your manuscript | www.dovepress.com                                                                                                                                                                                                                    
DovePress                                                                                                                                                              































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
immediately ramped down to 0 mA. In the final 30s, the 
current was ramped up to 2mA and back to 0 mA.
Instruments and Assessments
The tools used to evaluate the psychological state were 
validated in the Brazilian population and two trained psy-
chologists performed the assessments. We used the refined 
version of the State-Trait Anxiety Inventory (STAI).40 
State anxiety scores range from 13 to 52, and the trait 
anxiety scores from 12 to 36. A standardized questionnaire 
was applied to assess demographic data and medical 
comorbidities.
Outcomes
The primary outcome evaluated the change on NPS (0–10) 
by the delta (∆)-value (from post-intervention to pre-inter-
vention) during the conditioned pain modulation test (CPM- 
test). Secondary outcomes assessed the pain perception by 
delta (∆)-value (from post-intervention to pre-intervention) 
in the HPT, HPTo and Cold Pressor Test (CPT).
Outcomes Assessment
In this study, we evaluated pain as a response to a noci-
ceptive stimulus using the Quantitative Sensory Testing 
(QST), including the Conditioned Pain Modulation test 
(CPM-test) the Cold Pressor Test (CPT).
a) In order to perform the QST, we have used a com-
puterized version of the thermostat (Heat Pain 
Stimulator 1.1.10, Brazil).41 The participants 
remained seated, and a thermode (30x30 mm) was 
positioned on the forearm of the dominant side of the 
body. The temperature started at 30°C, and the ther-
mode was heated at a rate of 1.0°C/sec to a max-
imum of 51°C when the temperature began to drop. 
For the HPT, the participants were asked to press a 
button when they “felt the first heat pain”. The HPT 
was determined by the average of three evaluations 
with a 40s interval between them. Subsequently, 
“when the pain had reached its maximum” for the 
HPTo (this was done only once because of the pos-
sible sensitization effect).
b) To measure the CPM-test, we evaluated the pain 
intensity in two tonics HPT test stimuli separated 
by a CPM-test. Firstly, we applied the QST stimuli 
to produce a tonic stimulus (T0), and we instructed 
participants to press the button when the pain 
reached a magnitude of 6 on an NPS (0–10). This 
procedure was repeated three times, and we used the 
average of these temperatures for the test stimulus 
(T1). The CPM-test consisted of immersion of non- 
dominant hand for one minute in cold water at a 
temperature of 0 to 1 Celsius degree (°C). A thermo-
stat was used to control the water temperature, which 
was maintained from 0°C to 1°C. The QST proce-
dure was introduced after 30 seconds of non-domi-
nant hand on cold-water immersion to produce the 
test stimulus (T1). To determine the function of the 
DPMS, as indexed by the change on NPS (0–10) 
during CPM-test, we subtracted the pain score on 
NPS (0–10) during the presentation of the condition-
ing stimulus (cold water) [QST+CPM (T1)] from the 
pain score on NPS (6/10) during the tonic stimulus 
(T0) [score of CPM-test: score on the NPS (0–10) on 
T1 minus NPS (6/10) on T0].4 Higher CPM scores 
indicate a lower inhibitory function of the DPMS. 
This procedure is a standardized method to assess 
the function of DPMS.41
c) Cold pressor pain test (CPT) was induced by the 
submergence of the hand in cold water. During the 
test, the participant was asked to immerse the domi-
nant hand in ice-saturated water for a maximum of 2 
min (41–44). The temperature of the ice water was 
measured and across all tests, it ranged from 0°C to 
1°C. We instructed individuals to maintain their hand 
in the cold water for as long as the pain is bearable; 
once the pain had been unbearable, they could 
remove their hand, with ceiling time of 120 
seconds.42 The CPT is suggested to be a method 
that mimics the effects of chronic conditions effec-
tively because of its unpleasantness, and it has excel-
lent reliability and validity.42
d) BDNF. The laboratory outcome measured was the 
serum level of BDNF. We collected the blood samples 
before starting the assessment and after finishing the 
intervention. We centrifugate the blood samples for 10 
min, at 4500 rpm at 4°C and stored at −80°C for the 
hormone assay. The serum BDNF was determined 
using Enzyme-Linked Immunosorbent Assay 
(ELISA), using monoclonal-specific antibodies for 
BDNF (R&D Systems, Minneapolis, United States 
#DY248, BDNF lowest detection limit =11.7pg/mL).
Sample Size
The sample size was estimated by the G*Power software, 
based on previous study with a similar methodology 
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(Beltran 2019). The calculus indicated that would be 
necessary a sample size of 12 subjects to detect a 1.61 
point difference in the numerical scale of pain [(NPS 0– 
10), average SD 2.45, effect size equal to 0.65], with a 
power of 0.80 and an α error of 0.05.
Randomization
The randomization to allocate each participant was gener-
ated by a computer program (Randomlogue) in a ratio of 
1:1:1:1. They were allocated to receive the following 
interventions in incomplete crossover manner: a-tDCS/ 
HS, s-tDCS/HS, HS or a-tDCS, as described above in the 
session 4.3 about the experimental protocol. Random 
codes were placed in brown envelopes sealed with the 
subject’s sequence number # 48 on the outside of the 
envelope. The allocation concealment was reached on 
account of no investigator involved in the assessments 
was aware of intervention allocations.
Blinding
To control possible biases, the following strategies were 
established: Participants were instructed on all aspects 
related to the interventions during the evaluations. Two 
independent evaluators who were not aware of the inter-
vention received were trained to do the assessments. The 
randomization code was inside the brown envelopes pre-
pared before starting the study. The envelopes were sealed, 
initialed, and numbered sequentially. These envelopes 
were opened only after the participant had given her 
informed consent to participate in the study. The subject`s 
name and number were immediately sent to those respon-
sible for controlling the randomization process. The blind-
ing was gauged at the end of each evaluation.
Statistical Analysis
To summarize the main socio-demographic features of the 
sample and to compare the baseline characteristics accord-
ing to the allocation in the first trial was used the t-Test for 
independent samples. To test for normality, we used the 
Shapiro–Wilk test. To compare the mean of Δ-value 
between groups in univariate analysis was used the 
Kruskal–Wallis followed by Bonferroni correction to 
check for differences between groups.
It recognized that psychophysiological measures show 
individual reactivity to a stimulus of the same intensity. 
For example, one individual may be highly reactive into 
painful stimuli, whereas another shows limited changes 
receiving the same stimulus. Thus, to control for the 
inter-individual variability, we used the mean variation 
for delta (Δ)-values (post-intervention minus pre-interven-
tion) of the following measures: change on NPS (0–10) 
during the CPM test, CPT, HPT, and HPTo.43
Generalized linear models (GLM) were used to analyze 
the main effect for intervention group (a-tDCS, HS, a- 
tDCS/HS, and s-tDCS/HS) on the following outcomes 
measures (dependent variables): change on the NPS (0– 
10) during the CPM-test, HPT, HPTo and CPT. According 
to literature, age can mediate changes in BDNF signaling 
associated with both excitatory and inhibitory synapses in 
the prefrontal cortex26 as well as the response on a condi-
tioned stimulus. For these reasons, we included both as 
covariates in the GLM models.44 To perform the analyses, 
we used the software SPSS version 22.0 (SPSS, Chicago, 
IL, United States).
Results
Demographic and Characteristics of the 
Subjects
A total of 114 subjects were screened to participate. 
After applying the Waterloo-Stanford Group C (WSGC) 
Scale of Hypnotic Susceptibility, using a cutoff point (8/ 
12) for hypnotic suggestibility, 64 subjects were selected 
for the hypnosis experiment. Two subjects were excluded 
because we identified the presence of minor psychiatric 
disorders. The final sample comprised 48 subjects, which 
were allocated in two groups: 24 received single inter-
ventions (HS and tDCS in cross-over) and 24 received 
combined interventions (a-tDCS/HS and s-tDCS/HS in 
cross-over). Participants were randomized and assigned 
for group and intervention sequence. This resulted in 96 
evaluations (before and after intervention) for all out-
comes. The sample characteristics of the subjects accord-
ing to the sequence allocation in the first trial were 
comparable and are shown in Table 1. All subjects com-
pleted the protocol to which they had been randomized.
Primary Outcome
Intervention Effect on the NPS (0-10) During the 
CPM-Test
The mean of interventions group before and after the 
intervention assessed by the Δ-value of means (post-inter-
vention minus pre-intervention) in the NPS during the 
CPM-test (primary outcome) are presented in Table 2. 
The Δ-value means of the change on NPS (0–10) during 
CPM-test among groups were compared by Kruskal– 
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Wallis followed by Bonferroni correction to check for 
differences between groups.
Change NPS (0-10) During the CPM Test – 
Multivariate Analysis
A generalized linear model revealed a significant main effect 
for interventions group (Wald χ2 = 17.50, Df = 3, P <0.001) 
when we compared the Δ-values of NPS during the CPM test 
(mean post-intervention minus mean pre-intervention). This 
result is presented in Table 3. It showed that all three groups 
were statistically different than s-tDCS. BDNF serum levels at 
baseline were conversely correlated with the magnitude of the 
intervention effect on the DPMS as assessed by the CPM-test. 
While the increase in age is positively correlated with the score 
on NPS (0–10) during CPM-test. One could realize that higher 
values in the change of NPS (0–10) during the CPM-test 
suggest activation of endogenous facilitation of pain, increas-
ing the sensibility to painful stimuli, which indicates lower 
efficiency of DPMS. Thus, the increase in age is associated 
with lower efficiency of DPMS, and the higher levels of serum 
BDNF are associated with higher efficiency of DPMS.
The mean Δ-value (SD) of NPS during the CPM-test in 
the a-tDCS compared to HS was −0.54 (0.41) vs −0.01 
(0.41), respectively. This result indicates that the a-tDCS 
Table 1 Demographic and Clinical Characteristic of the Sample. Data are Presented as Mean and Standard Deviation (SD) According 
to Group in the First Trial (n=24)
a-tDCS First 
(n=24)
a-tDCS/Hypnotic Suggestion First (n=24) P-value
Demographic
Age (years) 26.64 (7.71) 25.42 (6.75) 0.72
Education Level (years) 15.67 (4.15) 15.27 (3.29) 0.97
Psychological measures, sleep quality measures and serum BDNF
Waterloo-Stanford Group Scale of Hypnotic Form C (WSGC) 8.58 (0.776) 8.95 (1.09) 0.31
Self-Reporting Questionnaire (SRQ-20) 2.83 (2.56) 2.73 (3.32) 0.99
Beck Depression Inventory (BDI – II) 8.00 (7.91) 7.41 (9.55) 0.68
Pain Catastrophizing Scale (PCS) 14.92(11.71) 14.05(11.84) 0.86
Central Sensitization Inventory (BP–CSI) 10.517(2.14) 11.835(2.52) 0.89
State-Anxiety (STAI) 23.96 (7.39) 23.05 (5.94) 0.35
Trait-Anxiety (STAI) 20.75 (4.68) 18.90 (3.21) 0.14
Pittsburgh Sleep Quality Index (PSQI) 5.00 (2.14) 4.85 (2.25) 0.22
Brain-derived neurotrophic factor (ng/mL) 38.17 (19.55) 42.51 (21.86) 0.30 $
Notes: Independent samples t-tests were used to compare groups, except for brain-derived neurotrophic factor. $For which Mann–Whitney Test was applied. 
Abbreviations: a-tDCS, active transcranial direct-current stimulation; BDNF, brain-derived neurotrophic factor; BP-CSI, Central Sensitization Inventory validated and 
adapted for a Brazilian Population; SRQ-20, Self-Reporting Questionnaire validated and adapted for a Brazilian Population with 20 items; STAI, State-Trait Anxiety Inventory; 
ng/mL, nanogram per milliliter.
Table 2 The Primary Outcome as Measured by the Change on the Numerical Pain Scale (NPS) (0–10) During Conditioned Pain 
Modulation Test (CPM-Test) According to the Intervention Group. Data are Presented as Mean and Standard Deviation (SD) and 
Delta [Δ-Value of Means (Post-Intervention Minus Pre-Intervention)] (n=48)
Mean (SD) Pre- Intervention Mean (SD) Post- Intervention Δ-value P-value £
Primary outcomes
Change on NPS (0–10) during CPM-test
a-tDCS (1) −0.97 (2.51) −1.33 (2.69) −0.54 (0.41) 2.3.4 0.030
Hypnotic suggestion (2) −1.91 (1.72) −2.04 (2.80) −0.01 (0.41) 1,3,4
a-tDCS/Hypnotic suggestion (3) −1.58 (1.85) −1.59 (2.55) −0.25(0.43) 1.2.4
s-tDCS/Hypnotic suggestion (4) −1.89 (2.21) −1.86 (2.37) 0.19 (0.43)
Notes: Numerical Pain Scale (NPS0-10). The differences are indicated via superscript numbers, which correspond to the respective groups labeled (1), (2), (3) or (4). 
£indicates comparisons between groups. We compared the change in the means between groups using the Δ-value by Kruskal–Wallis followed by Bonferroni correction to 
check for differences between groups. 
Abbreviations: a-tDCS, active transcranial direct-current stimulation; CPM-test, conditioned pain modulation test; s-tDCS, sham transcranial direct-current stimulation.
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compared to HS enhanced the efficiency of DPMS. The 
mean Δ-value (SD) of NPS during the CPM-test in the a- 
tDCS compared to the a-tDCS/HS was −0.54 (0.41) and 
−0.25 (0.43), respectively. This finding showed that the 
combined intervention reduced the efficiency of DPMS. 
Whereas, the mean Δ-value (SD) of NPS during the CPM- 
test in the HS compared to the s-tDCS/HS was −0.01 (0.41) 
and 0.19 (0.43), respectively. This combined intervention 
decreases the efficiency of DPMS. Whereas the group of a- 
tDCS/HS compared to s-tDCS/HS was −0.25 (0.43) and 
−0.19 (0.43), respectively. The s-tDCS/HS reduced the effi-
ciency of DPMS. The comparisons of means, according to 
the intervention group are presented in Figure 2.
Secondary Outcomes
HPT, HPTo, and CPT – Univariate Analysis
The effect of interventions group on the psychophysical 
measures assessed by the Δ-value (means post-interven-
tion minus pre-intervention) in the HPT, HPTo, and CPT 
are presented in Table 4. The Δ-value means on the HPT, 
HPTo, and CPT among groups were compared by 
Kruskal–Wallis followed by Bonferroni correction to 
check for differences between groups.
Secondary Outcomes: HPT, HPTo, and CPT – 
Multivariate Analysis
Generalized linear models analyses of the main effects of 
the intervention on the Δ-value of the HPT, HPT, and CPT 
are presented in Table 5. GLM revealed a main effect of 
the interventions on the Δ-HPTo (Wald χ2 =8.936, Df = 3, 
P <0.030) and the Δ-CPT (Wald χ2 = 10.233, Df = 3, P 
<0.017). For the Δ-HPT, we did not observe a significant 
difference between the interventions group (Wald χ2 
=6.299, Df = 3, P <0.098). The analysis showed that 
higher levels of BDNF in the baseline are positively cor-
related with a larger change in the Δ-value of CPT and in 
the HPTo. Age was not correlated with the change in these 
psychophysical measures.
The Δ-value (SD) of HPTo in the a-tDCS compared to the 
a-tDCS/HS was 0.12 (0.41) and 1.45 (0.42) respectively. The 
combined intervention increased the HPTo. Whereas, the Δ- 
value (SD) HPTo in the a-tDCS compared to s-tDCS/HS was 
0.12 (0.41) and 1.40 (0.42), respectively. The combined inter-
vention increased HPTo. Whereas in the HS compared to the 
s-tDCS/HS, the mean (SD) was 1.73 (0.41) and 1.40 (0.42), 
respectively. The s-tDCS/HS reduced the HPTo. The Δ-value 
mean (SD) of HPTo in the HS compared to the a-tDCS/HS 
was 1.73 (0.41) and 1.45 (0.42), respectively. The a-tDCS/HS 
reduced the HPTo. The comparisons of means, according to 
the intervention group are presented in Figure 3.
The Δ-value (SD) of CPT in the a-tDCS group com-
pared to the a-tDCS/HS was 4.63 (4.41) and 24.20 (4.62), 
respectively. The combined intervention increased the 
CPT almost six times. Whereas, the Δ-value (SD) CPT in 
the a-tDCS compared to s-tDCS/HS was 4.63 (4.41) and 
Table 3 Generalized Linear Model (GLM) to Assess the Intervention Effect Among Groups on Δ-Value (Post-Intervention Minus Pre- 
Intervention) of the Change on NPS (0–10) During the CPM-Test (n=48)
B SEM CI 95% Wald χ2 Df P-value Effect
Outcome: Δ-Change on NPS (0–10) during CPM-test size
(Intercept) 1.384 0.6490 (0.112 to 2.65) 4.551 1 0.033 -
a-t-DCS −4.131 1.021 (−6.13 to −2.13) 16.350 1 0.000 0.82
Hypnotic suggestion −2.277 0.9762 (−4.19 to −0.36) 5.440 1 0.020 0.48
a-tDCS/Hypnotic suggestion −1.433 0.8610 (−3.12 to 0.25) 2.771 1 0.096 0.34
s-tDCS/Hypnotic suggestion a - - - - - - -
Brain-derived neurotrophic factor (ng/mL) −.042 0.0144 (−0.07 to −0.02) 8.311 1 0.004
Age (years) 0.041 0.0172 (0.007 to 0.08) 5.668 1 0.017
Interaction intervention group * BDNF (ng/mL)
a-tDCS*BDNF 0.066 0.0192 (0.03 to 0.10) 11.848 1 0.001
Hypnotic suggestion*BDNF 0.045 0.0231 (0.00 to 0.09) 3.812 1 0.051
a-tDCS/Hypnotic suggestion*BDNF 0.037 0.0206 (−0.003 to 0.08) 3.206 1 0.073 -
s-tDCS/Hypnotic suggestion*BDNF a - - - - - - -
Notes: The Cramer’s V was used as a measure of effect size for qui-square tests. The effect size was interpreted as follows, for Df=1: 0.10=small effect; 0.30=medium effect; 
0.50=large effect. *Interaction between groups; aReference condition for pairwise comparisons between groups. 
Abbreviations: DF, degrees of freedom; a-tDCS, active transcranial direct-current stimulation; B, regression coefficient; BDNF, brain-derived neurotrophic factor; CPM- 
test, conditioned pain modulation test; CI, confidence interval; ng/mL, nanogram per milliliter; SEM, standard error of mean; s-tDCS, sham transcranial direct-current 
stimulation; Wald χ2, Wald chi-square test.
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9.55 (4.64), respectively. The combined intervention 
increased the CPT. The Δ-value mean (SD) CPT in the 
HS compared to the a-tDCS/HS was 15.48 (4.44) and 
24.20 (4.62), respectively. The a-tDCS/HS increased the 
CPT. The comparisons of means, according to the inter-
vention group are presented in Figure 4.
Figure 2 The change in the Numerical Pain Scale (NPS) (0–10) during Conditioned Pain Modulation test (CPM-test), assessed by the Δ-value (score post-intervention minus 
pre-intervention) in the four experimental groups. The error bars indicate standard error of the mean. The asterisk indicates all interventions were significantly different (P < 
0.05). All comparisons were performed by a Generalized Linear Model (GLM), followed by the Bonferroni test for post hoc multiple comparisons. 
Abbreviations: SEM, standard error of mean; tDCS, transcranial direct-current stimulation.
Table 4 Secondary Outcomes. Psychophysical Tests Heat Pain Threshold (HPT), Heat Pain Tolerance (HPTo), Cold Pressor Test 
(CPT) According to the Intervention Group. Data are Presented as Mean and Standard Deviation (SD) and Delta [Δ-Value of Means 
(Post-Intervention Minus Pre-Intervention)] (n=48)
Mean (SD) Pre-Intervention Mean (SD) Post- Intervention Δ-value P-value £
Heat pain threshold (HPT) oC
a-tDCS (1) 34.30 (0.66) 35.34(0.96) 1.28 (0.44) 0.175
Hypnotic suggestion (2) 34.18 (0.67) 36.79 (0.67) 2.78 (0.45)
a-tDCS/Hypnotic suggestion (3) 33.93 (0.66) 35.63(0.73) 1.69 (0.46)
s-tDCS/Hypnotic suggestion (4) 34.12 (0.77) 36.37(0.69) 1.59 (0.47)
Heat pain tolerance (HPTo) oC
a-tDCS (1) 45.16 (2.54) 45.16 (2.22) 0.12 (0.41) 2,3,4 0.003
Hypnotic suggestion (2) 44.71 (2.23) 46.10 (2.66) 1.73 (0.41) 1
a-tDCS/Hypnotic suggestion (3) 44.44 (2.49) 46.00 (2.53) 1.45 (0.42) 1
s-tDCS/Hypnotic suggestion (4) 45.59 (2.28) 47.08 (2.61) 1.40 (0.42) 1
Cold pressor test (CPT) in seconds
a-tDCS (1) 60.38 (39.74) 64.92 (39.83) 4.63 (4.41) 3 0.007
Hypnotic suggestion (2) 56.54 (38,93) 69.04 (39.45) 15.48 (4.44) 3
a-tDCS/hypnotic suggestion (3) 53.91 (33.73) 81.50 (35.85) 24.20 (4.62) 1,2,4
s-tDCS/hypnotic suggestion (4) 72.50 (2.12) 86.32 (2.61) 9.55 (4.64) 3
Notes: The differences are indicated via superscript numbers, which correspond to the respective groups labeled (1), (2), (3) or (4). £Indicates comparisons between 
groups. We compared the change in the means between groups using the Δ-value by Kruskal–Wallis followed by Bonferroni correction to check for differences between 
groups. 
Abbreviations: a-tDCS, active transcranial direct-current stimulation; SD, standard deviation; s-tDCS, sham transcranial direct-current stimulation.
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Discussion
The main finding in this study was to reveal that the hypnotic 
suggestion, when combined with the a-tDCS, reduced the 
efficiency of DPMS. Although this result contrasts with our 
initial hypothesis that the HS combined with the a-tDCS 
would enhance the efficiency on the DPMS, this effect is 
incompatible with floor or ceiling effects or with “inverted U- 
shaped dose-effect curve,” since to justify an inverted U- 
shaped effect, it should increase up to a maximum and then 
decrease. Hence, this result suggests that their effects are 
dissociated and by distinct mechanisms. Although the neu-
robiological processes involved in the impact of a-tDCS to 
modulate the DPMS are not clear, and the evidence of its 
effect over DLPFC on pain are incipient, we can at least 
propose, that there is an improvement in the DPMS even 
when the a-tDCS is applied to a distinct area of primary 
motor cortex (M1). In the present study, the a-tDCS 
improved the efficiency of DPMS more than fourfold com-
pared to s-tDCS/HS. This is a substantial size effect with a 
statistical significance and further clinical relevance, mainly 
because the dysfunction in the inhibitory DPMS is a central 
process in the chronic pain physiopathology.45 This finding 
suggests that a-tDCS induced downregulation of the pain- 
facilitation pathways (or an upregulation of the inhibitory 
function) of the DPMS. Given the results of a recent meta- 
analysis, the a-TDCS is effective in diverse chronic pain 
conditions, with more evidence when applied over M1, 
even though it suggests that it can be effective when it is 
used over DLPFC.46 This effect is plausible from the anato-
mical and neurophysiological perspective since the DLPFC 
is a critical structure for attention functions47 and modulates 
the inhibition of neuronal coupling along the ascending mid-
brain-thalamic-cingulate pathway through descending fibers 
from the prefrontal cortex.48 Thus, the stimulation over the 
Table 5 Generalized Linear Model (GLM) to Assess the Intervention Effect Among Groups on [Δ-Value of Means (Post-Intervention 
Minus Pre-Intervention)] on Heat Pain Threshold (HPT), Heat Pain Tolerance (HPTo), and Cold Pressor Test (CPT) (n=48)
B SEM CI 95% Wald χ2 Df P-value Effect
∆-Heat pain threshold (HPT) oC size
(Intercept) 2.234 1.0553 (0.16 to 4.30) 4.48 1 0.034 -
a-tDCS (1) −.313 0.6452 (−1.58 to 0.95) 0.235 1 0.628 -
Hypnotic suggestion (2) 1.187 0.6533 (−0.09 to 2.46) 3.30 1 0.069 -
a-tDCS/Hypnotic suggestion (3) 0.101 0.6579 (−1.18 to 1.39) 0.023 1 0.878 -
s-tDCS/Hypnotic suggestion (4) a - - - - - - -
Age (ys) −.489 0.3195 (−1.11 to 0.13) 2.33 1 0.126 -
Brain-derived neurotrophic factor (ng/mL) 0.224 0.1022 (0.023 to 0.43) 4.79 1 0.029
∆-Heat pain tolerance (HPTo) oC
(Intercept) 1.130 0.9807 (−0.79 to 3.05) 1.32 1 0.249 -
a-tDCS (1) −1.275 0.5926 (−2.43 to −0.11) 4.62 1 0.031 0.44
Hypnotic suggestion (2) 0.336 0.5958 (−0.83 to 1.50) 0.317 1 0.573 -
a-tDCS/Hypnotic suggestion (3) 0.054 0.5961 (−1.11 to 1.22) 0.008 1 0.927 -
s-tDCS/Hypnotic suggestion (4) a - - - - - - -
Age (ys) −.040 0.0307 (−0.10 to 0.02) 1.67 1 0.195 -
Brain-derived neurotrophic factor (ng/mL) 0.029 0.0093 (0.01 to 0.05) 9.76 1 0.002 -
∆-Cold pressor test (CPT)
(Intercept) 12.170 10.4816 (−8.37 to 32.71) 1.34 1 0.246 -
a-tDCS (1) −4.918 6.4082 (−17.47 to 7.64) 0.58 1 0.443 -
Hypnotic suggestion (2) 5.937 6.4887 (−6.78 to 18.65) 0.83 1 0.360 -
a-tDCS/Hypnotic suggestion (3) 14.656 6.5347 (1.84 to 27.46) 5.03 1 0.025 0.46
s-tDCS/Hypnotic suggestion (4) a 0a(reference)
Age (years) −.489 0.3195 (−1.11 to 0.13) 2.33 1 0.126 -
Brain-derived neurotrophic factor (ng/mL) 0.224 0.1022 (0.023 to 0.43) 4.79 1 0.029
Notes: Standard error of mean (SEM). The Cramer’s V was used as a measure of effect size for qui-square tests. The effect size was interpreted as follows, for Df=1: 
0.10=small effect; 0.30=medium effect; 0.50=large effect. aReference condition for pairwise comparisons between groups. 
Abbreviations: CI, confidence interval; DF, degrees of freedom; ∆-value, difference between pre and post intervention values; a-tDCS, active transcranial direct-current 
stimulation; B, regression coefficient; ng/mL, nanogram per milliliter; SD, standard deviation; SEM, standard error of mean; s-tDCS, sham transcranial direct-current 
stimulation; Wald χ2, Wald chi-square test.
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DLPFC can activate the descending nociceptive inhibitory 
control system (DNIC), since the prefrontal cortex is 
involved in pain control, pain expectation, and the placebo 
effect. However, it is pertinent to emphasize that our results 
were obtained in healthy subjects who do not present neuro-
biological changes related to central sensitization. Thus, due 
to complex mechanisms of pain and the possible dependency 
of tDCS effects on neuroplasticity state, further studies are 
needed to test the combined effect of a-tDCS/HS in chronic 
pain conditions.
The HS effect of reducing pain perception is a finding 
supported by a recent study with a similar experimental 
Figure 3 The change in heat pain tolerance (HPTo) measured in Celsius degree (°C) assessed by the Δ-value (temperature post-intervention minus pre-intervention) in the 
four experimental groups. The error bars indicate the standard error of the mean. The asterisk indicates a significant difference between the two groups (P < 0.05). All 
comparisons were performed by a Generalized linear model (GLM), followed by the Bonferroni test for post hoc multiple comparisons. 
Abbreviations: SEM, standard error of mean; tDCS, transcranial direct-current stimulation.
Figure 4 The change in cold pain tolerance (CPT) measured in seconds assessed by the Δ-value (time post-intervention minus pre-intervention) in the four experimental 
groups. The error bars indicate the standard error of the mean. The asterisk indicates a significant difference between the two groups (P < 0.05). All comparisons were 
performed by a Generalized linear model (GLM), followed by the Bonferroni test for post hoc multiple comparisons. 
Abbreviations: SEM, standard error of mean; tDCS, transcranial direct-current stimulation.
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paradigm.28 This result gives support for the idea that the 
hypnotic suggestion effect on pain processing is decoupled 
from the inhibitory function of the DPMS. Although the 
underlying mechanism is unclear, one can hypothesize that 
the reduction in the pain perception related to hypnotic 
suggestion mitigated the effect of heterotopic painful sti-
muli on the DPMS. It is plausible that the hypnotic sug-
gestion competes with the painful heterotopic stimuli by 
the same descending pain inhibitory pathways as well. An 
alternative explanation is that the hypnotic suggestion 
shifted attention and may have altered the brain processing 
of pain. This hypothesis is in agreement with a previous 
study, which observed that the hypnotic suggestion chan-
ged the activity on the anterior cingulate and insular 
cortex.49 There are evidences suggesting a shift in the 
attentional focus can lead to reduction of pain and reduc-
tion of brain activation in pain-related areas, such as ante-
rior cingulate and insular cortex and the thalamus.50 In the 
same way; hypnotic suggestion can have produced a “dis-
traction effect.” This could explain how the hypnotic sug-
gestion modulates pain perception at the supraspinal level 
and that emotions may modulate the inhibitory activity on 
the DPMS. Another explanation for this finding is that the 
a-tDCS may have changed the excitability in a large area 
of the prefrontal cortex with a consequent diminishing of 
the capacity for hypnotic response. This is plausible 
according to earlier studies when the transcranial magnetic 
stimulation (rTMS) in low frequency (1Hz) was applied 
over to the left DLPFC, and it reduced the hypnotic 
response beyond expectancy.51
According to our study, the hypnotic suggestion may 
modulate the pain reaction to HPTo and CPT differently. 
These results revealed no enhancement for HPTo for a- 
tDCS/HS compared to the interventions in which techniques 
were applied alone. However, an additive effect was 
observed for the a-tDCS/HS in the CPT, which increased 
more than two-fold compared to s-tDCS/HS, compared to 
HS, and a-tDCS. Earlier investigations found that a-tDCS is 
better than s-tDCS on acute pain perception in different 
conditions such as in experimental pain in healthy subjects,52 
acute postoperative pain,17 and various symptoms related to 
chronic pain syndromes.53 However, a critical factor that 
may contribute to a difference in the a-tDCS effect on pain 
perception is the site of stimulation. Thus, a plausible expla-
nation by the additive effect on the a-tDCS/HS in the CPT is 
that the anodal stimulation applied on the left DLPFC 
decreased the activity of the midbrain-medial thalamic path-
way related to the emotional perception of pain.46 Another 
factor that may be corroborated for this effect is the high 
hypnotic susceptibility of the subjects in this study. This is 
plausible, given individuals with higher hypnotic susceptibil-
ity tend to demonstrate more significant responses to analge-
sia suggestions during experimental pain paradigms (eg, cold 
pressor tests, painful heat stimuli).54 Additionally, cold pain 
and heat pain sensations have been linked to different psy-
chological and biological mechanisms.55 According to meta- 
analysis, different thermal stimuli (eg, heat or cold) both 
activate the anterior cingulate cortex (ACC) and insula.56 
The cold noxious stimuli activated right subgenual ACC 
and the amygdala, while the noxious heat stimulus activates 
the left ACC and the right thalamus.56 Thus, the more sub-
stantial effect related to a-tDCS/HS upon the CPT may be 
linked to a more substantial effect in the unpleasant emotion 
sensation, which is linked to the amygdala activation by cold 
nociceptive stimulus compared to uncomfortable feeling 
related to heat stimulus during the HPTo.57
Additionally, the more substantial effect of a-tDCS/HS 
may be linked to effects on the inhibitory control, as found 
in studies with fibromyalgia patients who received a-tDCS 
over DLPFC coupled with a Go/No-go task to modulate 
attentional networks.21 The a-tDCS, combined with the 
cognitive task to induce inhibition, increased HPT, and 
HPTo compared to s-tDCS.21 Another study in healthy 
subjects showed that a-tDCS over DLPFC combined 
with a brief cognitive intervention increased HPT and 
HPTo.58 Accordingly, it has been suggested that the 
tDCS effect is state-dependent23 and can modulate pre-
frontal circuitry and also induce a priming effect. Thus, a- 
tDCS/HS may work together to enhance the capacity to 
tolerate and downregulate the emotional component of the 
pain experience. Thus, HS can maintain these gains and 
create a potential synergistic effect. In this study, we did 
not observe the impact of a-tDCS on HPT. Our result 
aligns with another study with healthy subjects who 
received a-tDCS over the left DLPFC, which did not 
produce an effect with a significant impact on the HPT.59
The current study also expands data in the literature 
that collaborates with our previous studies upon the critical 
role of BDNF on the DPMS.60 This result is in agreement 
with an earlier study in healthy females, which showed 
that higher levels of BDNF have related to reducing pain 
perception.61 At date, our findings, together with the lit-
erature, suggest that in healthy subjects, the BDNF may 
increase the diffuse inhibition activated by a robust hetero-
topic stimulus applied in remote areas of the body.62 
Furthermore, this set of findings can give us the insight 
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to comprehend the role of the BDNF as a factor to predict 
the a-tDCS effect on the function of DPMS. And, it can 
provide us some theoretical support to understand the 
neurobiological processes underpinning to the a-tDCS 
impact found in previous studies on chronic pain condi-
tions (eg, osteoarthritis, fibromyalgia, hallux valgus, etc.).-
17,45,63 Additionally, we found that age is associated 
positively with the variations of Δ-value on NPS (0–10) 
during CPM-test. This indicates that the increase in age 
may be related to a decline in the efficacy of endogenous 
pain control mechanisms. Although we do not have a clear 
explanation for this result, the relationship between age 
and antidromic modulation of DPMS is a matter of intense 
debate. And, the literature related to this issue is mixed; 
then, more studies are needed to allow definitive 
conclusions.
This study has some methodological limitations that 
should be addressed. First, we included females in our sam-
ple since sex differences in response to pain have been 
found.64 We are conscious that the exclusion of men reduces 
external validity. However, we aimed to comprehend neuro-
physiological mechanisms. Thus, a homogeneous sample 
can minimize the risk of bias. Second, the absence of a 
group of subjects with a low hypnotizable propensity limits 
the scope of generalization of our results. Third, the effects of 
hypnosis after dehypnotization have been observed in earlier 
studies.65 However, it is not straightforward to quantify a 
residual potential impact and, if it exists, to identify how 
much of it has a real effect on the outcomes. From a prag-
matic view, we would need counterbalancing with the impact 
of inter-individual variability if we had compared different 
individuals on physiological measures, as in the case of 
psychophysical tests. This approach was used because, in 
this case, the starting point of these measures is individua-
lized, and the reactivity to the same stimulus can vary from 
one individual to another. Taking this into account, we con-
ducted a crossover study to consider this effect, if it exists, as 
an inherent characteristic of this intervention type. Even 
though we cannot exclude some carryover effect, we believe 
that it is unlikely to change the conclusions because the aim is 
to explore the combined intervention (eg, tDCS/HSA) and in 
both arms of combined interventions, the tDCS device was 
used, which can offer active or sham stimulation, according 
to randomization. Regarding the t-DCS, previous studies 
have shown that one session induces some aftereffect that 
could persist for one hour if we applied for only a course. 
Thereby, we assumed that the seven-day washout period is 
sufficient to prevent cumulative effects.66 Fourth, we did not 
observe a carryover effect, which means that the results for 
each phase of the experiment do not reflect the impacts of any 
residual effects of therapy provided during previous periods 
of the trial.67 Despite these limitations, our findings were 
evaluated using psychophysical parameters, which are less 
prone to assessment bias than self-reported measures. 
Finally, heat and cold pain have specific physiological 
mechanisms and can be interpreted in a very particular 
way,55 which may limit deducing the same effects to other 
somatosensorial modalities, such as mechanical pain.
In summary, these results indicate that the HS com-
bined with a-tDCS blunted the effect of the a-tDCS on the 
function of the DPMS. The a-tDCS up-regulates the inhi-
bition on DPMS, and the HS improved pain tolerance. 
And, together they enhanced the reaction time substan-
tially upon CPT.
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